Tamoxifen link to second tumours (BBC news online, 25 August 2009)
European Journal of Endocrinology Prize 2010

Algeta soars on $800 million Bayer drug alliance (Reuters, 3 September 2009)

17 Sept 2009

The Norwegian biotech company Algeta has signed a licensing deal for its main experimental drug Alpharadin, with German drugmaker Bayer.

Full article

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read